Valion Bio VBIO
NASDAQ VBIO
$2.51 -0.29 (-10.36%)
At close: Oct 1, 2026 · 4:00 PM EDT

Valion Bio (VBIO) Operating Leases (2021 - 2026)

Updated

Valion Bio (VBIO) reported Operating Leases of $9.49 million for Q2 2026.

Analysis

Valion Bio (VBIO) Operating Leases (2021 - 2026) Analysis & Trends

At the end of FY2023, Valion Bio posted Operating Leases of $176,000, down 52.0% from FY2022.

  • By year, Operating Leases came in at $367,000 in FY2022 (-32.7%) and $545,000 in FY2021.
  • The Q2 2026 figure ranks as the highest quarterly Operating Leases in data going back to Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Valion Bio 378,559.99 -19.06 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.49 Mn
Mar 31, 2024 141,000.00
Dec 31, 2023 176,000.00
Sep 30, 2023 242,000.00
Jun 30, 2023 275,000.00
Mar 31, 2023 323,000.00
Dec 31, 2022 367,000.00
Sep 30, 2022 413,000.00
Jun 30, 2022 461,000.00
Mar 31, 2022 504,000.00
Dec 31, 2021 545,000.00
API Access

Valion Bio Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=VBIO&period=max&api_key=YOUR_API_KEY